CHANDRA BHAGAT PHARMA : GETS BSE NOD FOR RS 29.04 CR PREFERENTIAL ISSUE

• BSE granted in-principle approval for issue of 66 lakh convertible warrants into 66 lakh equity shares • Warrants convertible at price not less than ₹44 per share, each of face value ₹10 • Issue to promoters and non-promoters on preferential basis • Total issue size at minimum price works out to ~₹29.04 Cr • Approval letter dated 12 October 2026; company disclosed to BSE on 13 October 2026

Chandra Bhagat Pharma Ltd

Open attachment

← Back to feed